Related Experiment Video

Updated: May 17, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Parents' emotional intelligence and children's type I diabetes management

Leehu Zysberg1, Tally Lang, Anna Zisberg

  • 1Department of Psychology, Tel Hai College, Tel Hai, Israel, 12210. Leehu@telhai.ac.il

Journal of Health Psychology
|October 30, 2012
PubMed

Insights

Parents' emotional intelligence is linked to better type I diabetes management in children. Higher emotional intelligence in caregivers correlated with improved glycemic control and fewer daily blood tests for diabetic children.

Area of Science:

  • Pediatric Endocrinology
  • Psychology
  • Health Outcomes Research

Background:

  • Type I diabetes requires significant daily management by caregivers.
  • Parental factors, such as emotional intelligence, may influence treatment adherence and outcomes.
  • Understanding these parental influences can optimize pediatric diabetes care.

Purpose of the Study:

  • To investigate the association between parents' emotional intelligence and their children's type I diabetes management.
  • To explore demographic factors that might correlate with diabetes outcomes.

Main Methods:

  • Eighty-one parents of children with type I diabetes completed emotional intelligence assessments and demographic questionnaires.
  • Diabetes management indicators, including hemoglobin A1c, daily blood tests, and blood glucose levels, were extracted from patient records.

Main Results:

  • Parental emotional intelligence showed a significant association with all measured glycemic control indicators.
  • Two different emotional intelligence measures yielded comparable, yet distinct, associations with outcomes.
  • Parental income level was also found to correlate with certain diabetes outcome measures.

Conclusions:

  • Parental emotional intelligence is a relevant factor in the glycemic control of children with type I diabetes.
  • The findings suggest that interventions aimed at enhancing parental emotional intelligence could potentially improve diabetes management.
  • Further research is warranted to explore the mechanisms linking emotional intelligence to pediatric diabetes outcomes.

Keywords:
diabetesemotional intelligenceemotionsfamilyhealth behaviorquantitative methods

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.